Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE

Part of paid clinical trials in Portland, Oregon.

Sponsor
OHSU Knight Cancer Institute
Study ID
NCT06011499
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Internet-Based Exercise Intervention — OTHER
    Participate in online supervised, group resistance training sessions (iLIVE)
  • Internet-Based Diet Intervention — OTHER
    Receive online access to an interactive website with a series of weekly self-directed and interactive sessions on various topics associated with diet and weight loss (iLIVE)
  • Education Intervention — OTHER
    Receive usual care receiving educational information about diet and exercise for cancer survivors

Study Details

This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.

Key Dates

Start date
Mar 12, 2024
Status verified
May 2026
Primary completion
Sep 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
250 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Arm I (iLIVE)
    Patients receive online access to an interactive weight loss website and participate in online group based resistance training sessions (iLIVE) on study. Patients also use a Fitbit fitness tracker and Aria smart scale while on study.
  • Active Comparator: Arm II (usual care)
    Patients receive usual care with access to online survivorship and exercise recommendations and use a Fitbit fitness tracker and Aria (registered trademark) smart scale while on study.

Primary Outcome Measure

Change in overweight/obesity [ Time Frame: At baseline, 3 months, 6 months and 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
OHSU Knight Cancer InstitutePortlandOregon97239
Kerri Winters-Stone
[email protected]
503-494-0813
Kerri Winters-Stone (PRINCIPAL_INVESTIGATOR)

Find similar trials in Portland, OR

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
OHSU Knight Cancer Institute· Portland, OR

Related Studies